Farmako
Engage in all european markets with a legal basis for medical cannabis.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor | €0.0 | round | |
| investor | €0.0 | round | |
N/A | Acquisition | ||
| Total Funding | 000k | ||
| EUR | 2019 |
|---|---|
| Revenues | 0000 |
| EBITDA | 0000 |
| Profit | 0000 |
| EV | 0000 |
| EV / revenue | 00.0x |
| EV / EBITDA | 00.0x |
| R&D budget | 0000 |
Source: Company filings or news article
Related Content
Farmako GmbH operates as a wholesaler focused on natural cannabinoid therapy, providing effective and fair-priced solutions. The company serves pharmacies and healthcare providers, offering products like the THC CBD combi test for identity testing of cannabis. Farmako operates in the medical cannabis market, emphasizing transparency and fair pricing to make health accessible to as many patients as possible. The business model revolves around wholesale distribution, earning revenue through the sale of cannabinoid products to pharmacies. Farmako's commitment to an open and transparent corporate culture drives its mission to improve patient care through innovative cannabinoid therapies.
Keywords: cannabinoid therapy, wholesale, fair pricing, THC CBD test, pharmacies, healthcare, transparency, medical cannabis, patient care, innovative solutions.